Provided by Tiger Trade Technology Pte. Ltd.

Alamar Biosciences

34.36
+1.905.85%
Post-market: 34.560.2000+0.58%19:30 EDT
Volume:339.92K
Turnover:11.62M
Market Cap:2.38B
PE:-47.99
High:34.62
Open:32.97
Low:32.80
Close:32.46
52wk High:38.54
52wk Low:18.85
Shares:69.31M
Float Shares:12.94M
Volume Ratio:0.62
T/O Rate:2.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7160
EPS(LYR):-2.5873
ROE:-33.57%
ROA:-13.53%
PB:7.61
PE(LYR):-13.28

Loading ...

BofA Initiates Alamar Biosciences at Neutral With $27 Price Target

MT Newswires Live
·
May 12

Alamar Biosciences, Inc. : Bofa Global Research Initiates Coverage With Neutral Rating and Price Objective $27.00

THOMSON REUTERS
·
May 12

Stifel Initiates Alamar Biosciences at Buy With $28 Price Target

MT Newswires Live
·
May 12

Alamar Biosciences Initiated at Buy by Stifel

Dow Jones
·
May 12

Alamar Biosciences Inc : TD Cowen Initiates Coverage With Buy Rating; Price Target $30

THOMSON REUTERS
·
May 12

Alamar Biosciences Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $35

THOMSON REUTERS
·
May 12

Alamar Biosciences initiated with a Buy at TD Cowen

TIPRANKS
·
May 12

Alamar Biosciences initiated with an Overweight at JPMorgan

TIPRANKS
·
May 12

Alamar Biosciences initiated with a Buy at Stifel

TIPRANKS
·
May 12

U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis

Reuters
·
May 12

Alamar Biosciences Q1 Loss Widens, Revenue Rises

MT Newswires Live
·
May 08

Earnings Flash (ALMR) Alamar Biosciences Posts Q1 Net Loss $1.74 a Share

MT Newswires Live
·
May 08

Alamar Biosciences Q1 FY26 net loss widens to $21.3 million; revenue rises 99% to $26 million

Reuters
·
May 08

Alamar Biosciences Inc - Cash and Equivalents $69.5 Mln as of March 31, 2026

THOMSON REUTERS
·
May 08

Alamar Biosciences: Q1 EPS $-1.74

THOMSON REUTERS
·
May 08

Alamar Biosciences Inc - Q1 2026 Revenue Rises to $26.0 Mln

THOMSON REUTERS
·
May 08

Press Release: Alamar Biosciences Reports First Quarter 2026 Financial Results

Dow Jones
·
May 08

Alamar Biosciences to present at BofA Securities 2026 Healthcare Conference

Reuters
·
May 06

Biotech firm Odyssey targets $810 million valuation in US IPO

Reuters
·
May 04

Alamar Biosciences Index Debut And Shelf Filing Reshape Investor Tradeoffs

Simply Wall St.
·
May 01